Your browser doesn't support javascript.
loading
eIF2ß, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
Tanaka, Ichidai; Sato, Mitsuo; Kato, Toshio; Goto, Daiki; Kakumu, Tomohiko; Miyazawa, Ayako; Yogo, Naoyuki; Hase, Tetsunari; Morise, Masahiro; Sekido, Yoshitaka; Girard, Luc; Minna, John D; Byers, Lauren A; Heymach, John V; Coombes, Kevin R; Kondo, Masashi; Hasegawa, Yoshinori.
Afiliación
  • Tanaka I; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Sato M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kato T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Goto D; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kakumu T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Miyazawa A; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yogo N; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hase T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Morise M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Sekido Y; Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Girard L; Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Minna JD; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Byers LA; Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Heymach JV; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Coombes KR; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
  • Kondo M; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hasegawa Y; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
Cancer Sci ; 109(6): 1843-1852, 2018 Jun.
Article en En | MEDLINE | ID: mdl-29624814
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Factor 2 Eucariótico de Iniciación / Regulación Neoplásica de la Expresión Génica / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Factor 2 Eucariótico de Iniciación / Regulación Neoplásica de la Expresión Génica / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido